Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 463123, 6 pages
http://dx.doi.org/10.1155/2014/463123
Research Article

Adenylyl Cyclase Signaling in the Developing Chick Heart: The Deranging Effect of Antiarrhythmic Drugs

1Department of Physiology, Faculty of Science, Charles University in Prague, 128 43 Prague, Czech Republic
2Institute of Physiology, Academy of Sciences of the Czech Republic, 142 20 Prague, Czech Republic
3Institute of Anatomy, First Faculty of Medicine, Charles University in Prague, 128 00 Prague, Czech Republic

Received 28 February 2014; Revised 14 May 2014; Accepted 29 May 2014; Published 23 June 2014

Academic Editor: Diego Franco

Copyright © 2014 Lucie Hejnova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Nanda, C. Nelson-Piercy, and L. Mackillop, “Cardiac disease in pregnancy,” Clinical Medicine, Journal of the Royal College of Physicians of London, vol. 12, no. 6, pp. 553–560, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Nickens, R. C. Long, and S. A. Geraci, “Cardiovascular disease in pregnancy (Women’s Health Series),” Southern Medical Journal, vol. 106, no. 11, pp. 624–630, 2013. View at Publisher · View at Google Scholar
  3. W. H. Frishman, “β-adrenergic blockade in cardiovascular disease,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 18, no. 4, pp. 310–319, 2013. View at Publisher · View at Google Scholar
  4. A. R. Caton, E. M. Bell, C. M. Druschel et al., “Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations,” Hypertension, vol. 54, no. 1, pp. 63–70, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Vasilakis-Scaramozza, A. Aschengrau, H. J. Cabral, and S. S. Jick, “Antihypertensive drugs and the risk of congenital anomalies,” Pharmacotherapy, vol. 33, no. 5, pp. 476–482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Y. Yakoob, B. T. Bateman, E. Ho et al., “The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis,” Hypertension, vol. 62, no. 2, pp. 375–381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Ruijtenbeek, J. G. R. De Mey, C. E. Blanco, and H. Ehmke, “The chicken embryo in developmental physiology of the cardiovascular system: A traditional model with new possibilities,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 283, no. 2, pp. R549–R551, 2002. View at Google Scholar · View at Scopus
  8. M. L. Kirby, “Innervation of the developing heart,” in Cardiac Development, pp. 179–197, Oxford University Press, 2007. View at Google Scholar
  9. D. Higgins and A. J. Pappano, “A histochemical study of the ontogeny of catecholamine-containing axons in the chick embryo heart,” Journal of Molecular and Cellular Cardiology, vol. 11, no. 7, pp. 661–668, 1979. View at Publisher · View at Google Scholar · View at Scopus
  10. N. G. Culver and D. A. Fischman, “Pharmacological analysis of sympathetic function in the embryonic chick heart,” The American Journal of Physiology, vol. 232, no. 3, pp. R116–R123, 1977. View at Google Scholar · View at Scopus
  11. D. E. Stewart and M. L. Kirby, “Endogenous tyrosine hydroxylase activity in the developing chick heart: a possible source of extraneuronal catecholamines,” Journal of Molecular and Cellular Cardiology, vol. 17, no. 4, pp. 389–398, 1985. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. M. Mulder, J. M. C. G. van Golde, A. A. C. van Goor, D. A. Giussani, and C. E. Blanco, “Developmental changes in plasma catecholamine concentrations during normoxia and acute hypoxia in the chick embryo,” Journal of Physiology, vol. 527, no. 3, pp. 593–599, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Zamenhof, “Selective sensitive period in chick embryo: toxic effect of exogenous neurotransmitters,” Cytobios, vol. 58, no. 234-235, pp. 171–177, 1989. View at Google Scholar · View at Scopus
  14. R. Kockova, J. Svatunkova, J. Novotny, L. Hejnova, B. Ostadal, and D. Sedmera, “Heart rate changes mediate the embryotoxic effect of antiarrhythmic drugs in the chick embryo,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 304, no. 6, pp. H895–H902, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. E. Vatner, K. Asai, M. Iwase et al., “Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart,” American Journal of Cardiology, vol. 83, no. 12, pp. 80H–85H, 1999. View at Google Scholar · View at Scopus
  16. S. B. Wachter and E. M. Gilbert, “Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application,” Cardiology, vol. 122, no. 2, pp. 104–112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Novotny, L. Bouřová, F. Kolář, and P. Svoboda, “Membrane-bound and cytosolic forms of heterotrimeric G proteins in young and adult rat myocardium: influence of neonatal hypo- and hyperthyroidism,” Journal of Cellular Biochemistry, vol. 82, no. 2, pp. 215–224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Salomon, C. Londos, and M. Rodbell, “A highly sensitive adenylate cyclase assay,” Analytical Biochemistry, vol. 58, no. 2, pp. 541–548, 1974. View at Publisher · View at Google Scholar · View at Scopus
  19. A. A. White, “Separation and purification of cyclic nucleotides by alumina column chromatography,” Methods in Enzymology, vol. 38, pp. 41–46, 1974. View at Publisher · View at Google Scholar · View at Scopus
  20. R. W. Alexander, J. B. Galper, E. J. Neer, and T. W. Smith, “Non-co-ordinate development of β-adrenergic receptors and adenylate cyclase in chick heart,” Biochemical Journal, vol. 204, no. 3, pp. 825–830, 1982. View at Google Scholar · View at Scopus
  21. S. W. Halvorsen and N. M. Nathanson, “Ontogenesis of physiological responsiveness and guanine nucleotide sensitivity of cardiac muscarinic receptors during chick embryonic development,” Biochemistry, vol. 23, no. 24, pp. 5813–5821, 1984. View at Publisher · View at Google Scholar · View at Scopus
  22. M. T. Phillips, M. L. Kirby, and D. E. Stewart, “Cyclic AMP in normal and sympathetically aneural chick hearts during development,” Journal of Molecular and Cellular Cardiology, vol. 18, no. 8, pp. 827–835, 1986. View at Publisher · View at Google Scholar · View at Scopus
  23. D. E. Stewart, M. L. Kirby, and R. S. Aronstam, “Regulation of β-adrenergic receptor density in the non-innervated and denervated embryonic chick heart,” Journal of Molecular and Cellular Cardiology, vol. 18, no. 5, pp. 469–475, 1986. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Brown, N. M. Deighton, S. Bals et al., “Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart,” Journal of Cardiovascular Pharmacology, vol. 19, no. 2, pp. 222–232, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. D. A. Jackson and N. M. Nathanson, “Subtype-specific regulation of muscarinic receptor expression and function by heterologous receptor activation,” Journal of Biological Chemistry, vol. 270, no. 38, pp. 22374–22377, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Dhein, P. Röhnert, S. Markau et al., “Cardiac beta-adrenoceptors in chronic uremia: studies in humans and rats,” Journal of the American College of Cardiology, vol. 36, no. 2, pp. 608–617, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. A. Alousi, J. R. Jasper, P. A. Insel, and H. J. Motulsky, “Stoichiometry of receptor-GS-adenylate cyclase interactions,” The FASEB Journal, vol. 5, no. 9, pp. 2300–2303, 1991. View at Google Scholar · View at Scopus
  28. T. A. Slotkin, J. T. Auman, and F. J. Seidler, “Ontogenesis of β-adrenoceptor signaling: Implications for perinatal physiology and for fetal effects of tocolytic drugs,” Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 1, pp. 1–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Venturini and S. B. Sparber, “Salicylate and cocaine: interactive toxicity during chicken mid-embryogenesis,” Free Radical Biology and Medicine, vol. 30, no. 2, pp. 198–207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. M. C. Garofolo, F. J. Seidler, M. M. Cousins, C. A. Tate, D. Qiao, and T. A. Slotkin, “Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver,” Brain Research Bulletin, vol. 59, no. 4, pp. 319–329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. L. Portbury, R. Chandra, M. Groelle et al., “Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 284, no. 6, pp. H2069–H2077, 2003. View at Google Scholar · View at Scopus
  32. V. J. Drake, S. L. Koprowski, N. Hu, S. M. Smith, and J. Lough, “Cardiogenic effects of trichloroethylene and trichloroacetic acid following exposure during heart specification of avian development,” Toxicological Sciences, vol. 94, no. 1, pp. 153–162, 2006. View at Publisher · View at Google Scholar · View at Scopus